NCT03185767

Brief Summary

the precise role of RNA in setting of this complication in systemic lupus erythematosus (SLE) is largely unknown

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

June 3, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 14, 2017

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2017

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

June 14, 2017

Status Verified

June 1, 2017

Enrollment Period

1.1 years

First QC Date

June 3, 2017

Last Update Submit

June 11, 2017

Conditions

Complication in Systemic Lupus Erythematosus

Outcome Measures

Primary Outcomes (1)

  • non coding RNA expression by real time PCR

    non coding RNA expression by real time PCR to evaluate thier role in lupus

    1 year

Study Arms (2)

SLE group

OTHER
Other: blood sampling

control group

OTHER
Other: blood sampling

Interventions

blood samplingOTHER

blood sampling

SLE groupcontrol group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • with systemic lupus

You may not qualify if:

  • vasculitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Cairo, 202, Egypt

RECRUITING

MeSH Terms

Interventions

Blood Specimen Collection

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
teaching assistant

Study Record Dates

First Submitted

June 3, 2017

First Posted

June 14, 2017

Study Start

June 1, 2016

Primary Completion

June 30, 2017

Study Completion

July 1, 2017

Last Updated

June 14, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will not share

Locations

EG(1)